Arsenate reductase II. Purine nucleoside phosphorylase in the presence of dihydrolipoic acid is a route for reduction of arsenate to arsenite in mammalian systems

Chemical Research in Toxicology

Volumn 15, Issue 5, 2002, Pages 692-698

  Radabaugh, Timothy R ^a   Sampayo Reyes, Adriana ^a,b   Zakharyan, Robert A ^a   Aposhian, H Vasken ^a  

^a University of Arizona   (United States)

^b INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

ARSENATE REDUCTASE; ARSENIC ACID DERIVATIVE; DIHYDROLIPOATE; DRINKING WATER; METHANEARSONIC ACID; OXIDOREDUCTASE; PHOSPHORYLASE; PURINE NUCLEOSIDE; PURINE NUCLEOSIDE PHOSPHORYLASE; UNCLASSIFIED DRUG;

ARTICLE; CARCINOGENICITY; CONTROLLED STUDY; ELECTROPHORESIS; ENZYME ACTIVITY; HUMAN; HUMAN TISSUE; ION EXCHANGE; ISOELECTRIC FOCUSING; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN PHOSPHORYLATION; PURIFICATION; REACTION ANALYSIS; REDUCTION; WATER CONTAMINATION;

ANIMALS; ANTIOXIDANTS; ARSENITE TRANSPORTING ATPASES; CATTLE; CHROMATOGRAPHY; DRUG INTERACTIONS; ELECTROPHORESIS; HUMANS; ION PUMPS; LIVER; MALE; MASS SPECTROMETRY; MULTIENZYME COMPLEXES; PURINE-NUCLEOSIDE PHOSPHORYLASE; THIOCTIC ACID;

MAMMALIA;

EID: 0036093079     PISSN: 0893228X     EISSN: None     Source Type: Journal    
DOI: 10.1021/tx0101853     Document Type: Article

References (48)

1. DMPS-arsenic challenge test. I: Increased urinary excretion of monomethylarsonic acid in humans given dimercaptopropane sulfonate
2. Arsenic ingestion and internal cancers: A review
3. Arsenic in drinking water and the prevalence of respiratory effects in West Bengal
4. Malignant neoplasms among residents of a Blackfoot disease-endemic area in Taiwan: High-arsenic artesian well water and cancers
5. Chronic arsenic poisoning in the north of Mexico
6. Enzymatic methylation of arsenic species and other new approaches to arsenic toxicity
7. Occurrence of monomethylarsonous acid in urine of humans exposed to inorganic arsenic
8. Enzymatic methylation of arsenic compounds: Assay, partial purification, and properties of arsenite methyltransferase and monomethylarsonic acid methyltransferase of rabbit liver
9. Human monomethylarsonic acid (MMA(V)) reductase is a member of the glutathione-S-transferase superfamily
10. Methylation of inorganic arsenic in different mammalian species and population groups
11. In vitro effect of arsenical compounds on glutathione-related enzymes
12. The cellular metabolism and systemic toxicity of arsenic
13. Methylated trivalent arsenic species are genotoxic
14. Metabolism of arsenic in primary cultures of human and rat hepatocytes
15. Purification and characterization of Acr2p, the Saccharomyces cerevisiae arsenate reductase
16. Interactions of rat red blood cell sulfhydryls with arsenate and arsenite
17. Arsenate reductase of Staphylococcus aureus plasmid pI258
18. Monomethylarsonous acid (MMA(III)) and arsenite: LD(50) in hamsters and in vitro inhibition of pyruvate dehydrogenase
19. Monomethylarsonous acid (MMAIII) is more toxic than arsenite in Chang human hepatocytes
20. Comparative toxicity of trivalent and pentavalent inorganic and methylated arsenicals in rat and human cells
21. Enzymatic reduction of arsenic compounds in mammalian systems: Reduction of arsenate to arsenite by human liver arsenate reductase
22. Purine nucleoside phosphorylase. Catalytic mechanism and transition-state analysis of the arsenolysis reaction
23. Mass spectrometric sequencing of protein silver-stained polyacrylamide gels
24. Purine nucleoside phosphorylase from human erythrocytes
25. Thymidine phosphorylase from Escherichia coli
26. The role of adenylic acid in the activation of phosphorylase
27. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
28. Calf spleen purine nucleoside phosphorylase: Purification, sequence and crystal structure of its complex with an N(7)-acycloguanosine inhibitor
29. Human purine nucleoside phosphorylase cDNA sequence and genomic clone characterization
30. Purine nucleoside phosphorylases: Properties, functions, and clinical aspects
31. Purine nucleoside phosphorylase. 1. Structure-function studies
32. Purine nucleoside phosphorylase deficiency
33. Structure-based design of inhibitors of purine nucleoside phosphorylase. 1. 9-(arylmethyl) derivatives of 9-deazaguanine
34. Purine nucleoside phosphorylase
35. Purine nucleoside phosphorylase from human erythrocytes: Physiocochemical properties of the crystalline enzyme
36. Analysis of lipoic acid by gas chromatography with flame
37. The pharmacology of the antioxidant lipoic acid
38. Alpha-DHLP in liver metabolism and disease
39. Study of inorganic arsenic methylation by rat liver in vitro: Relevance for the interpretation of observations in man
40. The partial purification and characterization of purine nucleoside phosphorylase from mammalian mitochondria
41. The biochemical action of arsonic acids especially as phosphate analogues
42. Purine ribonucleoside and deoxyribonucleoside phosphorylase in human erythrocytes
43. Phosphate supplementation of hypophosphataemia and parenteral nutrition
44. 31P NMR spectroscopy and its implications for metabolic control